Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
boston blog main
boston top stories
4
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
4
×
san diego top stories
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
gene therapy
hemophilia
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
biomarin pharmaceutical
celgene
pharmacy benefit managers
sangamo therapeutics
vc
2019
activism
acute hepatic porphyria
adeno-associated virus
What
gene
4
×
therapy
4
×
bio
roundup
drug
help
long
moves
patients
advanced
alnylam’s
approval
aren’t
becker
bff
billions
conference
crude
cutting
deals
despite
developers
devoted
disease
dollars
drugs
easl
eaton
edge
effects
encoded
fda
form
healthcare
illumina’s
imminent
impact
kicked
lasting
life
Language
Current search:
therapy
×
photo
×
" boston top stories "
×
gene
×
" san diego blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More